PetMed Express, Inc.PETSNASDAQ
Loading
| Metric | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 |
|---|---|---|---|---|---|
| Revenue Growth | -18.88% | -30.13% | -24.68% | -25.53% | -23.26% |
| Gross Profit Growth | -16.63% | +16.36% | -25.42% | -28.28% | -36.58% |
| EBITDA Growth | +0.00% | +0.00% | -618.45% | -367.04% | -810.39% |
| Operating Income Growth | +0.00% | +0.00% | -256.73% | -1612.64% | +0.00% |
| Net Income Growth | +0.00% | +0.00% | -1009.75% | -466.29% | +0.00% |
| EPS Growth | +0.00% | +0.00% | -1016.67% | -472.73% | +0.00% |
| EPS Diluted Growth | +0.00% | +0.00% | -1016.67% | -472.73% | +0.00% |
| Weighted Average Shares Growth | +1.03% | +0.96% | +1.18% | +1.41% | +1.81% |
| Weighted Average Shares Diluted Growth | +1.03% | +0.96% | -0.89% | -0.24% | +1.81% |
| Dividends per Share Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Operating Cash Flow Growth | +0.00% | -1.60% | +0.00% | -390.39% | +0.00% |
| Free Cash Flow Growth | +0.00% | -21.29% | +0.00% | -475.33% | +0.00% |
| Receivables Growth | +17.05% | -29.42% | -29.01% | +21.30% | -30.99% |
| Inventory Growth | -65.89% | -43.25% | -28.05% | +12.80% | +3.48% |
| Asset Growth | -16.47% | -15.07% | -28.08% | -31.32% | -39.25% |
| Book Value per Share Growth | -4.85% | -12.82% | -45.53% | -55.97% | -66.54% |
| Debt Growth | -32.70% | -31.50% | -33.16% | -36.74% | -41.00% |
| R&D Expense Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| SG&A Expenses Growth | -28.22% | +7.30% | +60.10% | +22.64% | +27.25% |